Australia
-
Aptar Pharma partners with Macquarie University on dry powder inhaled biologics
The collaboration comes as pharmaceutical developers explore alternative delivery routes for biologic medicines, which can present formulation and administration challenges because of their molecular size and complexity.
-
Telix inks US$1.67B acquisition deal for Germany’s ITM Isotope Technologies
Following completion of the acquisition, ITM shareholders are expected to hold 23.7% of Telix, while existing Telix shareholders will retain 76.3%.
-
Australian researchers develop world-first rapid diagnostic for iron deficiency
The test is now being evaluated for use in Sub-Saharan Africa, where researchers hope it could become the first validated rapid diagnostic test for iron deficiency.
-
WHO validates Australia as first high-income nation to eliminate trachoma
The achievement places Australia among 63 countries globally and 16 in the WHO Western Pacific Region that have eliminated at least one NTD.
-
Aspen Pharmacare to sell major Asia Pacific operations to BGH Capital for USD1.59B
The sale came about following an unsolicited offer from BGH Capital, which focuses on investments in Australia and New Zealand.